Oehrlein, Elisabeth M.
Luo, Xuemei
Savone, Mirko
Lobban, Trudie
Kang, Amiee
Lee, Brian
Gale, Rex
Schoch, Silke
Perfetto, Eleanor
Funding for this research was provided by:
Pfizer
Article History
Accepted: 29 October 2020
First Online: 23 December 2020
Declarations
:
: EMO, SS, and EP are employees of the National Health Council (NHC) who were paid consultants to Pfizer Inc. and Bristol Myers Squibb Company (BMS) in support of focus group preparations and development of the manuscript. NHC is a not-for-profit multi-stakeholder membership organization. As such, it receives membership and sponsorship funds from a variety of organizations and businesses. The lists of members and sponsors can be found at ExternalRef removed. XL and MS are paid employees of and own stocks in Pfizer Inc. TL is founder and CEO of the Arrhythmia Alliance and is a caregiver for two patients with AF. The Arrhythmia Alliance receives funding from life science companies, including the Pfizer-BMS Alliance in support of focus group preparations for this work. AK and BL are paid employees of and have equity/stocks in BMS. RG is a board member at the Arrhythmia Alliance and an AF patient.
: This project was supported by the Pfizer-Bristol Myers Squibb (BMS) Alliance.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Design and implementation of Advisory Board: All; Manuscript concept and design: All; Drafting of manuscript: EMO; Critical reviews: All; Final version approval: All.